Turning Confusion into Confidence: A Dermatologist's Guide to Genital Dermatoses and Gender Identity

In a presentation by a dermatologist discussing genital dermatoses, particularly hidradenitis suppurativa (HS), the focus was on the complexities of managing this condition, its emotional toll on patients, and the evolving treatment landscape. HS affects 0.5% to 2% of the population and can lead to significant pain and distress, often leaving patients feeling isolated and disbelieved. Essential to effective management is building rapport and ensuring patients feel heard. The talk highlighted the importance of comprehensive care, including addressing comorbidities and utilizing lifestyle changes like smoking cessation. Recent advancements in treatment options were emphasized, showcasing the exciting introduction of medications like secukinumab for HS and ongoing clinical trials for various new therapies. The presentation also underscored the need for timely intervention using biologics to improve patient outcomes and potentially prevent disease progression. Surgical options, including deroofing and other minor procedures, were discussed as beneficial in managing persistent cases. The speaker encouraged collaboration among healthcare providers and highlighted resources available from the HS Foundation for practitioners to facilitate treatment and insurance processes. Lastly, the speaker conveyed optimism for the future of HS management due to the growing array of treatment strategies on the horizon.